[#item_full_content] The DEA’s marijuana rescheduling hearing raises critical questions about the future of cannabis regulation and what Schedule III classification could mean for businesses, investors, and the broader industry. Harris Sliwoski attorney Jason Adelstone joins industry experts to discuss the latest developments from the hearing and the legal and business implications companies should monitor as the federal rescheduling process unfolds. 
Read More
